GVX 2026 - Global Vaccines Innovation and Immunology Conference

The Global Vaccines Innovation and Immunology Conference 2026 (GVX 2026) will take place from August 17 to 19 as a hybrid gathering hosted in London, United Kingdom & Online with full digital access for international participants. This high-level forum brings together experts from immunology, biotechnology, pharmaceutical research, clinical science, and public-health policy to examine how vaccines are being transformed by scientific and technological progress.
Vaccine Conference 2026 is designed to foster meaningful dialogue around emerging research, applied challenges, and strategic directions influencing vaccine discovery and deployment. The Immunology Congress will showcase advances in immune modulation, antigen design, delivery platforms, and analytical tools that are redefining how vaccines are conceived, tested, and produced. A strong focus will be placed on next-generation approaches, including messenger RNA systems, novel viral vectors, innovative adjuvant solutions, and broadly protective immunization strategies.
The scientific agenda features keynote presentations from global leaders, interactive panel discussions, focused research sessions, and case-driven learning forums. Beyond laboratory innovation, the conference also addresses real-world considerations such as manufacturing resilience, equitable distribution, regional preparedness, and regulatory evolution across different health systems.
Participants attending in London will benefit from face-to-face networking, technology showcases, poster sessions, and collaborative roundtables. Virtual attendees can engage through live-streamed presentations, moderated discussions, and an interactive exhibition platform, ensuring inclusive participation regardless of location.
By connecting research excellence with implementation insight, Immunization Conferences aims to strengthen global readiness against infectious diseases and support long-term public-health sustainability. This conference is well suited for professionals seeking to expand their expertise, build international partnerships, and remain at the forefront of innovation in vaccine science and immunology.